Mrs Meret Sarah Allemann
Zurich (Switzerland)
The gut-microbiome derived phenylacetylglutamine predicts adverse events in patients with acute coronary syndromes
Event: ESC Congress 2024
Topic: Biomarkers
Session: Advancing cardiac care in acute coronary syndromes: from genetics to social determinants
Gut-microbiota-derived phenylacetylglutamine induces oxidative stress in endothelial cells via a NOX2-dependent pathway
Event: ESC Congress 2023
Topic: Pathophysiology and Mechanisms
Session: Acute and chronic pathology of the venous system: a grey zone needing a spotlight
